Quarterly ResultAug 6, 2026, 04:40 PM
Alpha Teknova Q2 Revenue Up 18.45% to $12.19M; Net Loss Narrows
AI Summary
Alpha Teknova reported a significant increase in revenue for the second quarter of 2026, reaching $12.19 million, an 18.45% rise year-over-year. The company also narrowed its net loss to $3.17 million, or $(0.06) per share, compared to $(3.57) million, or $(0.07) per share, in the prior year. Cash used in operating activities improved to $(3.83) million for the six months ended June 30, 2026, from $(6.20) million in the same period last year, indicating a positive trend in operational efficiency.
Key Highlights
- Q2 2026 Revenue increased 18.45% to $12.19 million from $10.29 million in Q2 2025.
- Q2 2026 Net Loss narrowed to $(3.17) million, or $(0.06) per share, from $(3.57) million, or $(0.07) per share, in Q2 2025.
- YTD 2026 Cash used in operating activities improved to $(3.83) million from $(6.20) million YTD 2025.
- Q2 2026 Gross Profit rose 22.61% to $4.89 million from $3.98 million in Q2 2025.
- Q2 2026 Lab Essentials revenue was $9.18 million, up from $7.79 million in Q2 2025.
- Q2 2026 Clinical Solutions revenue was $2.43 million, up from $2.06 million in Q2 2025.
- Company was in compliance with financial covenants for its $28.245 million credit facility as of June 30, 2026.
Price Impact
More from TKNO